2025-08-05T16:10:04-05:00 2024-12-31 521738520 LANE & COMPANY CPAS 5335 WISCONSIN AVE NW WASHINGTON DC 20015 990 2024-01-01 460698754 FONDATION MERIEUX USA INC FOND 2023896245 1250 CONNECTICUT AVE NW 700 WASHINGTON DC 20036 LOUIS DELORME CHIEF EXECUTIVE OFFICER 2023896245 2025-06-16 1 1 ROBERT E LANE P01622353 2026172615 2025-08-05 X 2024 2025-03-06 01:10:19Z LOUIS DELORME 1250 CONNECTICUT AVE NW SUITE 700 WASHINGTON DC 20036 585175 0 X WWW.FONDATION-MERIEUXUSA.ORG X 2011 DE THE MERIEUX FOUNDATION USA IS A PUBLIC CHARITY DEDICATED TO BUILDING CAPACITY IN DEVELOPING COUNTRIES TO IMPROVE DIAGNOSTIC CAPABILITIES FOR LOCAL HEALTHCARE, AND FOR THE SURVEILLANCE, ALERT AND RESPONSE TO INFECTIOUS DISEASE EPIDEMICS. 6 6 2 7 0 0 776080 585175 0 0 0 0 0 0 776080 585175 228238 299129 0 0 249824 359293 0 0 103639 197669 195757 675731 854179 100349 -269004 919346 673772 348544 371974 570802 301798 THE MERIEUX FOUNDATION USA IS A PUBLIC CHARITY DEDICATED TO BUILDING CAPACITY IN DEVELOPING COUNTRIES TO IMPROVE DIAGNOSTIC CAPABILITIES FOR LOCAL HEALTHCARE, AND FOR THE SURVEILLANCE, ALERT AND RESPONSE TO INFECTIOUS DISEASE EPIDEMICS. 0 0 327226 299129 0 THE FOUNDATION PERFORMED THE FOLLOWING PROGRAMS IN 2024, LARGELY THROUGH GRANT EXPENDITURES: BIOSAFETY AND BIOSECURITY TRAININGS, AND LABORATORY MAINTENANCE, AND FUNDED BY THE U.S. DEFENSE THREAT REDUCTION AGENCY (DTRA). THE FOUNDATION'S EFFORTS TOWARDS USAID'S INFECTIOUS DISEASE DETECTION AND SURVEILLANCE (IDDS) PROJECT IN MADAGASCAR AND DEMOCRATIC REPUBLIC OF CONGO INCLUDED TRAINING, LABORATORY CAPACITY BUILDING AND SUPERVISION AND POLICY DEVELOPMENT. 327226 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 2 1 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 0 0 X ALINE FRIMON 2023896245 1250 CONNECTICUT AVE NW STE 700 WASHINGTON DC 20036 DR DAVID L HEYMANN PRESIDENT/CHAIR 2.00 X X 0 0 0 DR WARREN JOHNSON VICE CHAIR/TREASURER 1.00 X X 0 0 0 MS KARINE MEHLER SECRETARY 0.50 X X 0 0 0 DR JON ANDRUS DIRECTOR 1.00 X 0 0 0 MS CLARE O'BRIEN DIRECTOR 1.00 X 0 0 0 MR DIDIER CHERPITEL DIRECTOR 1.00 X 0 0 0 LOUIS DELORME CEO 40.00 X 27980 0 12411 KOREN WOLMAN-TARDY FORMER CEO 40.00 X 156613 0 64867 184593 0 77278 1 1 1 0 0 109929 475246 585175 585175 0 0 0 299129 299129 261871 15722 206826 39323 55175 3869 43027 8279 13572 488 11042 2042 28675 1031 23331 4313 2050 2050 24300 24300 53138 7012 33877 12249 15994 20 5112 10862 7822 6084 1738 2710 2710 101985 77152 24833 6914 6914 FORIEGN EXCHANGE (GAINS -19156 -45 -19111 854179 327226 423314 103639 517147 576206 402111 90798 0 6680 88 88 919346 673772 348544 371974 348544 371974 X 570802 301798 570802 301798 919346 673772 -269004 0 X X 0 1 X 1 0 X 2839730 2897603 2617580 776080 585175 9716168 2839730 2897603 2617580 776080 585175 9716168 6242364 3473804 0 26 0 0 0 26 9716194 0.35750 0.33460 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 585175 0 585175 0 585175 854179 0 854179 0 854179 PART X, LINE 2: MANAGEMENT ANNUALLY REVIEWS ITS TAX POSITIONS AND HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION ON THE FINANCIAL STATEMENTS. 1 SUB-SAHARAN AFRICA 0 0 GRANTMAKING LAB CAPACITY BUILDING, MAINTENANCE, AND TRAINING 129333 SOUTH ASIA 0 0 GRANTMAKING EDUCATIONAL GRANT 37950 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING EDUCATIONAL GRANT 37950 0 0 0 0 0 0 205233 0 205233 SUB-SAHARAN AFRICA COORDINATE ONE HEALTH APPROACH TO RISK ASSESSMENT OF HEMORRHAGIC FEVER 109929 WIRE 0 SUB-SAHARAN AFRICA INFECTIOUS DISEASE DETECTION AND SURVEILLANCE PROGRAM 19404 WIRE 0 SOUTH ASIA EDUCATIONAL GRANT 37950 WIRE 0 EAST ASIA AND THE PACIFIC EDUCATIONAL GRANT 37950 WIRE 0 4 0 0 0 0 0 0 PART 1, LINE 2 ON A REGULAR BASIS, FMX USA REQUIRES PROGRAMMATIC UPDATES AND FINANCIAL REPORTS, INCLUDING A TRANSACTION LIST WITH SUPPORTING DOCUMENTS AND TIMESHEETS. FMX USA ALSO HAS REGULAR MEETINGS WITH PARTNERS AND GRANT RECIPIENTS TO TRACK TECHNICAL DELIVERABLES AND BUDGET SPENDING. 0 0 0 0 0 0 0 0 0 KOREN WOLMAN-TARDY FORMER CEO 112216 0 22775 0 21622 0 0 0 64867 0 221480 0 0 0 FORM 990, PART VI, SECTION A, LINE 8B FONDATION MERIEUX DOES NOT HAVE ANY SUBCOMMITTEES OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED BY MANAGEMENT. A COPY WAS SHARED WITH THE BOARD OF DIRECTORS PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS AND DIRECTORS ARE ANNUALLY REQUIRED TO SIGN A CONFLICT OF INTEREST POLICY STATEMENT. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD MEETING. AFTER THE PRESENTATION, THEY LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. THE CHAIRPERSON OF THE GOVERNING BOARD, IF APPROPRIATE, APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD DETERMINES WHETHER THE CORPORATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD DETERMINES BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE CORPORATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION, IT MAKES ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. IF THE GOVERNING BOARD HAS A REASONABLE CAUSE TO BELIEVE A MEMBER HAS FAILED TO DISCLOSE ACTUAL OR POSSIBLE CONFLICTS OF INTEREST, IT INFORMS THE MEMBERS OF THE BASIS FOR SUCH BELIEF AND AFFORDS THE MEMBER AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. IF, AFTER HEARING THE MEMBER'S RESPONSE AND AFTER MAKING FURTHER INVESTIGATION AS WARRANTED BY THE CIRCUMSTANCES, THE GOVERNING BOARD DETERMINES THE MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT TAKES APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION. FORM 990, PART VI, SECTION B, LINE 15A THE COMPENSATION IS REVIEWED ANNUALLY IN PERFORMANCE REVIEWS WITH THE CHAIRPERSON OF THE BOARD AND DIRECTOR GENERAL OF FONDATION MERIEUX. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. PART XII, LINE 2C THE COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT AND THE PROCESS USED TO OVERSEE THE AUDIT HAVE NOT CHANGED FROM THE PRIOR YEAR.